Skip to main content
Log in

Generic substitution by pharmacists could be cost saving in US

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Darrow JJ, et al. Reconsidering the scope of US state laws allowing pharmacist substitution of generic drugs. BMJ 2020: No. 369, 23 Jun 2020. Available from: URL: https://doi.org/10.1136/bmj.m2236

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Generic substitution by pharmacists could be cost saving in US. PharmacoEcon Outcomes News 856, 1 (2020). https://doi.org/10.1007/s40274-020-6901-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-6901-7

Navigation